Natural course of human papillomavirus (HPV) infection. Effectiveness of HPV analysis in cervical swabs;Naturlicher verlauf der HPV-infektion. Nutzen der HPV-analytik in der zervixdiagnostik

Pathologe

Volumn 20, Issue 1, 1999, Pages 15-24

  Milde Langosch, Karin ^a   Riethdorf, Sabine ^a   Park, Tjoung Won ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cervical cancer; Cervical dysplasia; HPV detection; Papillomaviruses

Indexed keywords

ARTICLE; CANCER GENETICS; CANCER GRADING; CANCER GROWTH; CARCINOGENESIS; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PROGNOSIS; SEROLOGY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS DETECTION; VIRUS GENOME; VIRUS ONCOGENE; WART VIRUS; BIOPSY; CELL TRANSFORMATION; GENETICS; PAPILLOMA VIRUS; PATHOGENICITY; PATHOLOGY; PRECANCER; RISK FACTOR; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIRULENCE; VIRUS INFECTION;

BIOPSY; CELL TRANSFORMATION, NEOPLASTIC; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VIRULENCE;

EID: 0032613002     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002920050315     Document Type: Article

References (30)

1. Benton C, Shahidullah H, Hunter JAA (1992) Human papillomavirus in the immuno-suppressed. Papillomavirus Rep 3:23-26
2. Blanton RA, Perez-Reyez N, Merrick DT, McDougall JK (1991) Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture. Am J Pathol 138:673-685
3. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87:796-802
4. Cope JU, Hildesheim A, Schiffman MH, Manos MM, Lörincz AT, Burk RD, Glass AG, Greer C, Buckland J, Helgesen K, Scott DR, Sherman ME, Kurman RJ, Liaw-K-L (1997) Comparison of the Hybrid Capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol 35:2262-2265
5. Cox JT, Lörincz AT, Schiffmann MH (1995) HPV testing by hybrid capture is useful in triaging women with a cytologic diagnosis of ASQUS. Am J Obstet Gynecol 1172:946
6. Cromme FJ, Meijer CJLM, Snijders PJF, Uyterlöinde A, Kenemans P, Heimerhorst T, Stern PL, Van den Brule AJC, Walboomers JMM (1993) Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. Br J Cancer 67:1372-1380
7. Cullen AP, Reid R, Campion M, Lorincz AT (1991) Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasia. J Virol 65:606-612
8. Dillner J, Lehtinen M, Björge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, Hakulinen T, Thoresen S, Hakama M (1997) Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst 89:1293-1299
9. Dürst M, Glitz D, Schneider A, zur Hausen H (1992) Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 189:132-140
10. Heck D, Yee CL, Howley PM, Munger K (1992) Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc Natl Acad Sci USA 89:4442-4446
11. Heiland A, Olsen AO, Gjoen K, Akselsen HE, Sauer T, Magnus P, Borresen-Dale AL, Ronningen KS (1998) An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women. Int J Cancer 76:19-24
12. Ho GYF, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S (1995) Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87:1365-1371
13. Jacobs N, Moutschen MP, Franzen-Detrooz E, Boniver V, Boniver J, Delvenne P (1998) Organotypic culture of HPV-transformed keratinocytes: a model for testing lymphocyte infiltration of (pre)neoplastic lesions of the uterine cervix. Virchows Arch 432:323-330
14. Jacobs MV, de Roda Husman AM, van den Brule AJC, Snijders PJF, Meijer CJLM, Walboomers JMM (1995) Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonudeotide probes. J Clin Microbiol 33:901-905
15. Klingelhutz AJ, Foster SA, McDougall JK (1996) Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380:79-81
16. Lörincz AT, Reid R, Jenson AB, Greenburg MD, Lancaster W, Kurman RJ (1992) Human papillomavirus infection of the cervix: relative risk associations of 15 common anognital types. Obstet Gynecol 79:328-337
17. Lowy DR, Schiller JT (1998) Papillomaviruses and cervical cancer: pathogenesis and vaccine development. Monogr Natl Cancer Inst 23:27-30
18. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinksy SM (1989) Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209-213
19. May M, Dong X-P, Beyer-Finkler E, Stubenrauch F, Fuchs PG, Pfister H (1994) The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation pf target sequences for YY1. EMBO J 13:1460-1466
20. McIndoe WA, McLean MR, Jones RW, Mullins PR (1984) The invasive potential of carcinoma in situ of the cervix. Obstet Gynecol 64:451-458
21. Milde-Langosch K, Schreiber C, Becker G, Löning T, Stegner H-E (1993) Human papilomavirus detection in cervical adenocarcinomas by polymerase chain reaction. Human Pathol 24:590-594
22. Park T-W, Fujiwara H, Wright TC (1995) Molecular biology of cervical cancer and its precursors. Cancer 76:1902-1913
23. Park T-W, Richart RM, Sun X-W, Wright TC (1996) Correlation between HPV type and clonal status of cervical squamous intraepithelial lesions (SIL). J Natl Cancer Inst 88:355-358
24. Riethdorf L, Riethdorf S, Gützlaff K, Prall F, Löning T (1996) Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus 16-infected squamous intraepithelial lesions and squamous cell carcinomas of the Cervix uteri. Am J Pathol 149:1469-1475
25. Rösl F, Lengert M, Albrecht J, Kleine K, Zawatzky R, Schraven B, zur Hausen H (1994) Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cell lines and derived hybrids. J Virol 68:2142-2150
26. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S, Stanton CK, Manos MM (1993) Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85:958-964
27. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393:229-234
28. Turek LP (1994) The structure, function and regulation of papillomaviral genes in infection and cervical cancer. Adv Viral Res 44:305-356
29. Walboomers JMM, de Roda Husman A-M, Snijders PJF, Stel HV, Risse EKJ, Heimerhorst TJM, Voorhorst FJ, Meijer CJLM (1995) Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol 48:728-732
30. Zur Hausen H (1994) Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. In: Current topics in microbiology and immunology 186:131-156